Atlas Trials

Study of Chidamide as a Single-agent Treatment for Patients With Relapse or Refractory B-NHL

Clinical trial NCT03245905 · UNKNOWN

Trial details

NCT number
NCT03245905
Sponsor
Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma (NHL)
Start date
2017-08-20
Primary completion
2021-12-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.